ELIOS develops a technology that restores the normal flow of aqueous humor in glaucoma patients, effectively reducing intraocular pressure. This approach directly addresses the risk of vision loss associated with elevated eye pressure, providing a targeted solution for managing glaucoma.
Funding
Funding not disclosed
Founders
Product
Problem
Glaucoma, a leading cause of irreversible blindness, is characterized by elevated intraocular pressure (IOP) that damages the optic nerve. Traditional treatments often involve eye drops or invasive surgeries, which can have compliance issues or significant side effects. There is a need for less invasive and more effective methods to manage IOP and prevent vision loss in glaucoma patients.
Solution
ELIOS Vision offers a laser-based technology designed to restore the natural outflow of aqueous humor, effectively reducing intraocular pressure in glaucoma patients. This minimally invasive procedure targets the underlying cause of elevated IOP by creating microchannels in the trabecular meshwork, facilitating fluid drainage. The ELIOS procedure aims to provide a long-term solution for managing glaucoma, reducing or eliminating the need for daily eye drops and avoiding the risks associated with more invasive surgical interventions. By improving the natural drainage pathways, ELIOS helps to protect the optic nerve and preserve vision in patients with glaucoma.
Target Audience
The primary target audience includes ophthalmologists and glaucoma specialists seeking advanced, minimally invasive treatment options for their adult patients with glaucoma.
Features
- Utilizes a precise laser to create microchannels in the trabecular meshwork.
- Restores the natural outflow of aqueous humor, reducing intraocular pressure.
- Minimally invasive procedure performed in an outpatient setting.
- Aims to reduce or eliminate the need for IOP-lowering eye drops.
- Designed to provide a long-term solution for glaucoma management.
- CE marked and licensed for use in the EU.